-
1.
公开(公告)号:US20220396563A1
公开(公告)日:2022-12-15
申请号:US17366670
申请日:2021-07-02
发明人: Jason Allan WILES , Avinash S. PHADKE , Milind DESHPANDE , Atul AGARWAL , Dawei CHEN , Venkat Rao GADHACHANDA , Akihiro HASHIMOTO , Godwin PAIS , Qiuping WANG , Xiangzhu WANG , Joel Charles BARRISH , William GREENLEE , Kyle J. EASTMAN
IPC分类号: C07D401/14 , C07D403/14 , C07D409/14 , C07D471/04 , C07D471/08 , C07D491/107 , C07D498/10 , C07F5/02
摘要: Complement Factor D inhibitors, pharmaceutical compositions, and uses thereof, as well as processes for their manufacture are provided. The compounds provided include Formula I, Formula II, Formula III, Formula IV, and Formula V, or a pharmaceutically acceptable salt, prodrug, isotopic analog, N-oxide, or isolated isomer thereof, optionally in a pharmaceutically acceptable composition. The inhibitors described herein target Factor D and inhibit or regulate the complement cascade.
-
2.
公开(公告)号:US20220315562A1
公开(公告)日:2022-10-06
申请号:US17835098
申请日:2022-06-08
发明人: Jason Allan WILES , Avinash S. PHADKE , Milind DESHPANDE , Atul AGARWAL , Dawei CHEN , Venkat Rao GADHACHANDA , Akihiro HASHIMOTO , Godwin PAIS , Qiuping WANG , Xiangzhu WANG , William GREENLEE
IPC分类号: C07D403/04 , C07D401/14 , C07D403/14 , C07D471/04 , C07D413/14 , C07F9/6558 , C07D417/14 , C07D487/04 , C07D519/00 , C07D403/12 , C07D407/14 , C07D409/14 , C07D403/10 , C07D513/04 , C07D487/22 , A61P37/00 , A61P1/16 , A61P29/00 , C07D405/14 , C07D493/04
摘要: Compounds, methods of use, and processes for making inhibitors of complement Factor D are provided comprising Formula I, I″ and I′″ or a pharmaceutically acceptable salt or composition thereof. The inhibitors described herein target Factor D and inhibit or regulate the complement cascade. The inhibitors of Factor D described herein reduces the excessive activation of complement.
-
公开(公告)号:US20230287005A1
公开(公告)日:2023-09-14
申请号:US18124427
申请日:2023-03-21
发明人: Jason Allan WILES , Avinash S. PHADKE , Milind DESHPANDE , Atul AGARWAL , Dawei CHEN , Venkat Rao GADHACHANDA , Akihiro HASHIMOTO , Godwin PAIS , Qiuping WANG , Xiangzhu WANG
IPC分类号: C07D513/04 , C07D403/14 , C07D401/14 , C07D471/04 , C07D417/14 , C07D413/14 , C07D487/04 , C07D405/14 , C07D409/14 , C07D495/04 , C07D493/04 , C07D403/06
CPC分类号: C07D513/04 , C07D403/14 , C07D401/14 , C07D471/04 , C07D417/14 , C07D413/14 , C07D487/04 , C07D405/14 , C07D409/14 , C07D495/04 , C07D493/04 , C07D403/06
摘要: Compounds, methods of use, and processes for making inhibitors of complement Factor comprising Formula I, or a pharmaceutically acceptable salt or composition thereof wherein R12 or R13 on the A group is an aryl, heteroaryl or heterocycle (R32) are provided. The inhibitors of Factor D described herein reduce the excessive activation of complement.
-
公开(公告)号:US20210269458A1
公开(公告)日:2021-09-02
申请号:US17015171
申请日:2020-09-09
发明人: Jason Allan WILES , Avinash S. PHADKE , Milind DESHPANDE , Atul AGARWAL , Dawei CHEN , Venkat Rao GADHACHANDA , Akihiro HASHIMOTO , Godwin PAIS , Qiuping WANG , Xiangzhu WANG
IPC分类号: C07D513/04 , C07D403/14 , C07D401/14 , C07D471/04 , C07D417/14 , C07D413/14 , C07D487/04 , C07D405/14 , C07D409/14 , C07D495/04 , C07D493/04 , C07D403/06
摘要: Compounds, methods of use, and processes for making inhibitors of complement Factor D comprising Formula I, or a pharmaceutically acceptable salt or composition thereof wherein R12 or R13 on the A group is an aryl, heteroaryl or heterocycle (R32) are provided. The inhibitors of Factor D described herein reduce the excessive activation of complement.
-
5.
公开(公告)号:US20230357199A1
公开(公告)日:2023-11-09
申请号:US18196128
申请日:2023-05-11
发明人: Jason Allan WILES , Avinash S. PHADKE , Milind DESHPANDE , Atul AGARWAL , Dawei CHEN , Venkat Rao GADHACHANDA , Akihiro HASHIMOTO , Godwin PAIS , Qiuping WANG , Xiangzhu WANG , Joel Charles BARRISH , William GREENLEE , Kyle J. EASTMAN
IPC分类号: C07D401/14 , C07D403/14 , C07D409/14 , C07D471/04 , C07D471/08 , C07D491/107 , C07D498/10 , C07F5/02
CPC分类号: C07D401/14 , C07D403/14 , C07D409/14 , C07D471/04 , C07D471/08 , C07D491/107 , C07D498/10 , C07F5/027
摘要: Complement Factor D inhibitors, pharmaceutical compositions, and uses thereof, as well as processes for their manufacture are provided. The compounds provided include Formula I, Formula II, Formula III, Formula IV, and Formula V, or a pharmaceutically acceptable salt, prodrug, isotopic analog, N-oxide, or isolated isomer thereof, optionally in a pharmaceutically acceptable composition. The inhibitors described herein target Factor D and inhibit or regulate the complement cascade.
-
公开(公告)号:US20230071620A1
公开(公告)日:2023-03-09
申请号:US17872104
申请日:2022-07-25
发明人: Jason Allan WILES , Avinash S. PHADKE , Milind DESHPANDE , Atul AGARWAL , Dawei CHEN , Venkat Rao GADHACHANDA , Akihiro HASHIMOTO , Godwin PAIS , Qiuping WANG , Xiangzhu WANG , Joel Charles BARRISH , William GREENLEE , Kyle J. EASTMAN
IPC分类号: C07D401/14 , C07D403/06 , C07D403/10 , C07D405/14 , C07D409/14 , C07D417/14 , C07D471/04 , C07D493/04 , C07D495/04 , C07D513/04 , C07F9/6558
摘要: Complement Factor D inhibitors, pharmaceutical compositions, and uses thereof, as well as processes for their manufacture are provided. The compounds provided include Formula I, Formula II, Formula III, and Formula IV or a pharmaceutically acceptable salt, prodrug, isotopic analog, N-oxide, or isolated isomer thereof, optionally in a pharmaceutically acceptable composition. The inhibitors described herein target Factor D and inhibit or regulate the complement cascade.
-
公开(公告)号:US20210122733A1
公开(公告)日:2021-04-29
申请号:US17135184
申请日:2020-12-28
发明人: Jason Allan WILES , Avinash S. PHADKE , Milind DESHPANDE , Atul AGARWAL , Dawei CHEN , Venkat Rao GADHACHANDA , Akihiro HASHIMOTO , Godwin PAIS , Qiuping WANG , Xiangzhu WANG , William GREENLEE
IPC分类号: C07D401/14 , C07D495/04 , A61K45/06 , C07D487/04 , C07D209/12 , C07D519/00 , C07D403/14 , C07D513/04 , C07D405/14 , C07D403/12 , C07D401/12
摘要: Compounds, methods of use, and processes for making inhibitors of complement Factor D are provided comprising Formula I, I″ and I′″ or a pharmaceutically acceptable salt or composition thereof. The inhibitors described herein target Factor D and inhibit or regulate the complement cascade. The inhibitors of Factor D described herein reduces the excessive activation of complement.
-
-
-
-
-
-